Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jul 15;92(4):715-7.
doi: 10.1016/j.ijrobp.2015.02.051.

Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses

David I Rosenthal  1 , Clifton D Fuller  2 , Lester J Peters  3 , Howard D Thames Jr  4
Affiliations
Comment

Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses

David I Rosenthal et al. Int J Radiat Oncol Biol Phys. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none.

Comment on

References

    1. Beitler JJ, Zhang Q, Fu KK, et al. Final results of local-regional control and late toxicity of RTOG 9003: A randomized trial of altered fractionation radiation for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2014;89:13–20. - PMC - PubMed
    1. Marcial VA, Pajak TF, Chang C, et al. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary-report) by the Radiation Therapy Oncology Group (RTOG) Int J Radiat Oncol Biol Phys. 1987;13:41–47. - PubMed
    1. Bentzen SM, Thames HD. Dose-response relationships for late radiation effects in the head and neck: Regarding the analysis of the RTOG 8313 trial, Fu et al. IJROBP 32:577–588; 1995. Int J Radiat Oncol Biol Phys. 1996;34:523–524. - PubMed
    1. Cox JD, Pajak TF, Marcial VA, et al. Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts—results from Radiation-Therapy Oncology Group protocol 8313. Int J Radiat Oncol Biol Phys. 1991;20:1191–1195. - PubMed
    1. Hutcheson KA, Lewin JS, Barringer DA, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer. 2012;118:5793–5799. - PMC - PubMed

MeSH terms